Diabetes

Company inks exclusive distribution agreement for diabetes treatment

Published in Obesity and Diabetes Week, March 22nd, 2004

HEE Corp. (HCCF) has signed a worldwide exclusive distribution agreement with Thomlinson Trade & Investments, Inc., of Switzerland for a medical procedure for the treatment of type 2 diabetes.

The signing of the distribution agreement grants HEE Corp. worldwide exclusivity for this new procedure. Sandy Winick, president, HEE Corp., said they expect to start licensing the treatments once the first group of patients has successfully received the treatment, which will be administered at a United States university or medical institution. The treatment could be available by the summer of 2004.

HEE Corp. has been engaged in the discovery and development of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-03-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry